full.am
  • am
  • en
  • ru
USD 391.56
EUR 428.21
RUB 4.77

Letrozole(FeMara) CAS 112809-51-5

  • Նուբարաշեն
  • 16/01/2025 11:54

Անհատ

[email protected]

  • Ընկերության անվանումը

    Letrozole(FeMara) CAS 112809-51-5

  • Աշխատանքային ոլորտ

    Առանց փորձի, Ուսանողներ

  • Գրաֆիկ

    Լրիվ աշխատանքային օր

  • Կրթություն

  • Փորձ

    CAS No.112809-51-5

    Chemical Name:Letrozole

    SynonymsLETROZOL;FEMARA;LETRAZOLE;LetrozoleUsp28;Letrozole(FeMara);Letroz;etrozoL;Lelrozol;Lerozole;Laiquzuo

    CBNumber:CB9286355

    Molecular Formula:C17H11N5

    Molecular Weight:285.3

    Melting point 181-183°C

    Boiling point 563.5±60.0 °C(Predicted)

    Density 1.21±0.1 g/cm3(Predicted)

    storage temp. 2-8°C

    solubility DMSO: >50mg/mL

    pka 1.52±0.11(Predicted)

    Uses

    A nonsteroidal aromatase inhibitor structurally related to Fadrozole. Antineoplastic

    Uses

    Letrozole has been used:

    in organoid growth assay to determine its inhibitory capacity(48)

    to investigate steroid receptor coactivator-1 (SRC-1) mediated endogenous estrogen regulation of hippocampal PSD-95(49)

    to determine its effects on tumor-induced hyperalgesia(50)

    for hormonal manipulation in rats(51)

    to study its effects on lipocalin-2 (Lcn2)(52)

    to determine its effects on mechanical hyperalgesia and aromatase expression(53)

  • Նախընտրելի սեռ

  • Նախընտրելի տարիք

  • Նկարագիր

  • CAS No.112809-51-5

    Chemical Name:Letrozole

    SynonymsLETROZOL;FEMARA;LETRAZOLE;LetrozoleUsp28;Letrozole(FeMara);Letroz;etrozoL;Lelrozol;Lerozole;Laiquzuo

    CBNumber:CB9286355

    Molecular Formula:C17H11N5

    Molecular Weight:285.3

    Melting point 181-183°C

    Boiling point 563.5±60.0 °C(Predicted)

    Density 1.21±0.1 g/cm3(Predicted)

    storage temp. 2-8°C

    solubility DMSO: >50mg/mL

    pka 1.52±0.11(Predicted)

    Uses

    A nonsteroidal aromatase inhibitor structurally related to Fadrozole. Antineoplastic

    Uses

    Letrozole has been used:

    in organoid growth assay to determine its inhibitory capacity(48)

    to investigate steroid receptor coactivator-1 (SRC-1) mediated endogenous estrogen regulation of hippocampal PSD-95(49)

    to determine its effects on tumor-induced hyperalgesia(50)

    for hormonal manipulation in rats(51)

    to study its effects on lipocalin-2 (Lcn2)(52)

    to determine its effects on mechanical hyperalgesia and aromatase expression(53)

Տարածել